Sign inGet started

YOUNG WILLIAM D

Insider CIK 1217420 · BMRN Director · THRX Director · TBPH Director · PRAX Director · AUTL Director · VRTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AUTL Autolus Therapeutics plc A Award deriv2026-06-292026-07-0131,667— $031,667SEC↗
AUTL Autolus Therapeutics plc A Award deriv2026-06-292026-07-0147,500— $047,500SEC↗
PRAX Praxis Precision Medicines A Award deriv2026-06-102026-06-12648— $0648SEC↗
PRAX Praxis Precision Medicines A Award2026-06-102026-06-121,371— $03,269SEC↗
PRAX Praxis Precision Medicines A Award deriv2025-06-262025-06-2710,520— $010,520SEC↗
PRAX Praxis Precision Medicines A Award deriv2024-06-052024-06-068,566— $08,566SEC↗
PRAX Praxis Precision Medicines A Award deriv2023-06-122023-06-1428,981— $028,981SEC↗
PRAX Praxis Precision Medicines A Award deriv2022-05-262022-05-2722,753— $022,753SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2022-04-262022-04-2828,000— $028,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2022-04-262022-04-289,852— $078,010SEC↗
PRAX Praxis Precision Medicines A Award deriv2021-06-082021-06-0922,343— $022,343SEC↗
PRAX Praxis Precision Medicines J Other2021-05-132021-07-0728,473— $028,473SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2021-04-272021-04-296,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2021-04-272021-04-299,828— $068,158SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2020-06-012020-06-034,527— $04,527SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2020-04-282020-04-306,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2020-04-282020-04-306,635— $058,330SEC↗
VRTX VERTEX PHARMACEUTICALS INC M Exercise deriv2020-01-022020-01-0620,000— $00SEC↗
VRTX VERTEX PHARMACEUTICALS INC M Exercise2020-01-022020-01-0620,000$72.14 $1.44M29,311SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2020-01-022020-01-062,500$217.72 $544.3K26,811SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2020-01-022020-01-067,266$218.73 $1.59M19,545SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2020-01-022020-01-06100$220.08 $22.0K9,311SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2020-01-022020-01-0610,134$219.37 $2.22M9,411SEC↗
VRTX VERTEX PHARMACEUTICALS INC M Exercise deriv2019-12-302020-01-0230,000— $00SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2019-12-302020-01-0221,798$218.93 $4.77M10,111SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2019-12-302020-01-027,402$218.05 $1.61M31,909SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2019-12-302020-01-02300$221.16 $66.3K9,311SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2019-12-302020-01-02500$220.25 $110.1K9,611SEC↗
VRTX VERTEX PHARMACEUTICALS INC M Exercise2019-12-302020-01-0230,000$65.65 $1.97M39,311SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award2019-06-012019-06-042,381— $09,311SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2019-04-302019-05-026,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2019-04-302019-05-028,385— $051,695SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2018-06-012018-06-053,229— $03,229SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award2018-06-012018-06-051,801— $06,930SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2018-05-012018-05-036,000— $06,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2018-05-012018-05-038,186— $043,310SEC↗
VRTX VERTEX PHARMACEUTICALS INC M Exercise deriv2017-06-012017-06-055,295— $05,295SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award2017-06-012017-06-052,188— $05,129SEC↗
TBPH Theravance Biopharma, Inc. A Award2017-05-172017-05-186,000— $035,124SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2016-06-012016-06-037,073— $07,073SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award2016-06-012016-06-032,941$0.01 $292,941SEC↗
TBPH Theravance Biopharma, Inc. A Award2016-05-032016-05-056,000— $029,124SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award deriv2015-06-102015-06-183,300— $03,300SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award2015-06-102015-06-181,100— $011,875SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2015-06-012015-06-0320,000— $020,000SEC↗
TBPH Theravance Biopharma, Inc. A Award2015-04-222015-04-246,000— $023,124SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award deriv2014-06-042014-06-066,600— $06,600SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award2014-06-042014-06-062,100— $010,775SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2014-06-032014-06-0512,000— $012,000SEC↗
TBPH Theravance Biopharma, Inc. A Award deriv2014-06-032014-06-0512,000— $012,000SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2014-06-012014-06-0320,000— $020,000SEC↗
THRX THERAVANCE INC A Award deriv2014-05-222014-05-276,000— $06,000SEC↗
THRX THERAVANCE INC A Award2014-05-222014-05-276,000— $083,935SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2014-05-072014-05-0930,000— $030,000SEC↗
THRX THERAVANCE INC M Exercise deriv2014-04-072014-04-0925,806— $00SEC↗
THRX THERAVANCE INC M Exercise2014-04-072014-04-0925,806$9.69 $250.1K77,935SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award deriv2013-05-152013-05-178,500— $08,500SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award2013-05-152013-05-173,400— $08,675SEC↗
THRX THERAVANCE INC A Award deriv2013-04-242013-04-266,000— $06,000SEC↗
THRX THERAVANCE INC A Award2013-04-242013-04-266,000— $052,129SEC↗
THRX THERAVANCE INC A Award deriv2012-05-152012-05-176,000— $06,000SEC↗
THRX THERAVANCE INC A Award2012-05-152012-05-176,000— $046,129SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award deriv2012-05-082012-05-108,500— $049,750SEC↗
BMRN BIOMARIN PHARMACEUTICAL IN A Award2012-05-082012-05-103,400— $05,275SEC↗